Log in

NASDAQ:KALAKala Pharmaceuticals News Headlines

$8.90
+0.03 (+0.34 %)
(As of 04/10/2020 06:31 AM ET)
Add
Compare
Today's Range
$8.61
Now: $8.90
$9.07
50-Day Range
$5.35
MA: $7.07
$8.97
52-Week Range
$3.24
Now: $8.90
$9.66
Volume629,468 shs
Average Volume1.94 million shs
Market Capitalization$343.27 million
P/E RatioN/A
Dividend YieldN/A
Beta0.08

Headlines

Kala Pharmaceuticals (NASDAQ KALA) News Headlines

Source:
DateHeadline
Kala Pharmaceuticals Inc (NASDAQ:KALA) Receives Average Rating of "Buy" from BrokeragesKala Pharmaceuticals Inc (NASDAQ:KALA) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - April 4 at 1:30 AM
Kala Pharmaceuticals Announces Exercise of Underwriters’ Option to Purchase Additional SharesKala Pharmaceuticals Announces Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - April 3 at 5:36 PM
Kala Pharmaceuticals Looks To Keep Rally GoingKala Pharmaceuticals Looks To Keep Rally Going
seekingalpha.com - March 31 at 4:48 PM
Kala Pharmaceuticals (NASDAQ:KALA) Stock Rating Reaffirmed by WedbushKala Pharmaceuticals (NASDAQ:KALA) Stock Rating Reaffirmed by Wedbush
www.americanbankingnews.com - March 29 at 8:25 AM
Short Interest in Kala Pharmaceuticals Inc (NASDAQ:KALA) Grows By 28.2%Short Interest in Kala Pharmaceuticals Inc (NASDAQ:KALA) Grows By 28.2%
www.americanbankingnews.com - March 28 at 9:28 PM
Kalas Upcoming NDA Submission For EYSUVIS Is A Great Catalyst OpportunityKala's Upcoming NDA Submission For EYSUVIS Is A Great Catalyst Opportunity
seekingalpha.com - March 24 at 2:41 PM
$2.69 Million in Sales Expected for Kala Pharmaceuticals Inc (NASDAQ:KALA) This Quarter$2.69 Million in Sales Expected for Kala Pharmaceuticals Inc (NASDAQ:KALA) This Quarter
www.americanbankingnews.com - March 23 at 7:03 AM
Kala Pharmaceuticals Inc (NASDAQ:KALA) Expected to Post Earnings of -$0.54 Per ShareKala Pharmaceuticals Inc (NASDAQ:KALA) Expected to Post Earnings of -$0.54 Per Share
www.americanbankingnews.com - March 21 at 2:26 AM
Q1 2020 EPS Estimates for Kala Pharmaceuticals Inc (NASDAQ:KALA) Raised by WedbushQ1 2020 EPS Estimates for Kala Pharmaceuticals Inc (NASDAQ:KALA) Raised by Wedbush
www.americanbankingnews.com - March 20 at 8:54 AM
Kala Pharmaceuticals (NASDAQ:KALA) Receives "Buy" Rating from WedbushKala Pharmaceuticals (NASDAQ:KALA) Receives "Buy" Rating from Wedbush
www.americanbankingnews.com - March 18 at 6:17 PM
HC Wainwright Raises Kala Pharmaceuticals (NASDAQ:KALA) Price Target to $13.00HC Wainwright Raises Kala Pharmaceuticals (NASDAQ:KALA) Price Target to $13.00
www.americanbankingnews.com - March 18 at 3:51 PM
Kala Pharmaceuticals Inc (NASDAQ:KALA) COO Buys $57,500.00 in StockKala Pharmaceuticals Inc (NASDAQ:KALA) COO Buys $57,500.00 in Stock
www.americanbankingnews.com - March 17 at 8:24 PM
Kala Pharma launches equity offering; shares down 2% after hoursKala Pharma launches equity offering; shares down 2% after hours
seekingalpha.com - March 11 at 1:46 PM
Kala pharmaceuticals up 16% premarket after pricing stock offeringKala pharmaceuticals up 16% premarket after pricing stock offering
seekingalpha.com - March 11 at 8:46 AM
BRIEF-Kala Pharma Says Notified Jefferies About Suspending, Terminating Prospectus Related To Sales DealBRIEF-Kala Pharma Says Notified Jefferies About Suspending, Terminating Prospectus Related To Sales Deal
www.reuters.com - March 11 at 8:46 AM
BRIEF-Kala Pharmaceuticals Announces Pricing Of Public Offering Of 16 Mln Shares Of StockBRIEF-Kala Pharmaceuticals Announces Pricing Of Public Offering Of 16 Mln Shares Of Stock
www.reuters.com - March 10 at 11:22 PM
Kala Pharmaceuticals Announces Pricing of Public Offering of 16,000,000 Shares of Common StockKala Pharmaceuticals Announces Pricing of Public Offering of 16,000,000 Shares of Common Stock
finance.yahoo.com - March 10 at 11:22 PM
BRIEF-Kala Pharmaceuticals Announces Proposed Public Offering Of Common StockBRIEF-Kala Pharmaceuticals Announces Proposed Public Offering Of Common Stock
www.reuters.com - March 10 at 6:22 PM
Kala Pharmaceuticals Announces Proposed Public Offering of Common StockKala Pharmaceuticals Announces Proposed Public Offering of Common Stock
finance.yahoo.com - March 10 at 6:22 PM
Top Ranked Momentum Stocks to Buy for March 10thTop Ranked Momentum Stocks to Buy for March 10th
finance.yahoo.com - March 10 at 1:22 PM
Kala Pharmaceuticals, Inc. (KALA) Shares March Higher, Can It Continue?Kala Pharmaceuticals, Inc. (KALA) Shares March Higher, Can It Continue?
finance.yahoo.com - March 10 at 1:22 PM
Is Kala Pharmaceuticals (KALA) Outperforming Other Medical Stocks This Year?Is Kala Pharmaceuticals (KALA) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - March 10 at 1:22 PM
BRIEF-Kala Pharma Announces Results For Primary And Secondary Endpoints In Stride 3 Clinical Trial Evaluating EysuvisBRIEF-Kala Pharma Announces Results For Primary And Secondary Endpoints In Stride 3 Clinical Trial Evaluating Eysuvis
www.reuters.com - March 9 at 11:43 PM
How Kala Pharma Is Surviving Mondays Market CarnageHow Kala Pharma Is Surviving Monday's Market Carnage
247wallst.com - March 9 at 1:43 PM
Noteworthy Thursday Option Activity: BLK, TTD, KALANoteworthy Thursday Option Activity: BLK, TTD, KALA
www.nasdaq.com - March 5 at 4:37 PM
Kala Pharmaceuticals: Solid ProgressKala Pharmaceuticals: Solid Progress
seekingalpha.com - February 17 at 1:48 PM
Kala Pharma +12% premarket after Q4 reportKala Pharma +12% premarket after Q4 report
seekingalpha.com - February 12 at 6:26 PM
BRIEF-Kala Pharma Posts Q4 Loss Per Share Of $0.63BRIEF-Kala Pharma Posts Q4 Loss Per Share Of $0.63
www.reuters.com - February 12 at 1:25 PM
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q4 2019 Results - Earnings Call TranscriptKala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - February 12 at 1:25 PM
Kala Pharmaceuticals (KALA) Reports Q4 Loss, Lags Revenue EstimatesKala Pharmaceuticals (KALA) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - February 12 at 1:25 PM
Has Kala Pharmaceuticals (KALA) Outpaced Other Medical Stocks This Year?Has Kala Pharmaceuticals (KALA) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - February 12 at 1:25 PM
Kala Pharmaceuticals EPS misses by $0.03, misses on revenueKala Pharmaceuticals EPS misses by $0.03, misses on revenue
seekingalpha.com - February 12 at 8:25 AM
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial ResultsKala Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - February 12 at 8:25 AM
Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference CallKala Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call
finance.yahoo.com - February 6 at 12:53 PM
Biogen Soars on Patent Win for MS Drug Tecfidera Over MylanBiogen Soars on Patent Win for MS Drug Tecfidera Over Mylan
finance.yahoo.com - February 6 at 12:53 PM
Aimmune's Palforzia Wins FDA Approval for Peanut AllergyAimmune's Palforzia Wins FDA Approval for Peanut Allergy
finance.yahoo.com - February 3 at 12:00 PM
Intercept (ICPT) Concludes Enrollment in Study on NASH DrugIntercept (ICPT) Concludes Enrollment in Study on NASH Drug
finance.yahoo.com - January 30 at 1:05 PM
Kala Pharma completes enrollment in late-stage study of Eysuvis in dry eye diseaseKala Pharma completes enrollment in late-stage study of Eysuvis in dry eye disease
seekingalpha.com - January 15 at 11:42 PM
Kala Pharmaceuticals Announces Completion of Enrollment of STRIDE 3 Trial for EYSUVIS™ (KPI-121 0.25%) for Dry Eye DiseaseKala Pharmaceuticals Announces Completion of Enrollment of STRIDE 3 Trial for EYSUVIS™ (KPI-121 0.25%) for Dry Eye Disease
finance.yahoo.com - January 15 at 8:39 AM
Investors Who Bought Kala Pharmaceuticals (NASDAQ:KALA) Shares A Year Ago Are Now Down 13%Investors Who Bought Kala Pharmaceuticals (NASDAQ:KALA) Shares A Year Ago Are Now Down 13%
finance.yahoo.com - January 14 at 5:36 PM
Kala Pharmaceuticals to Present at 38th Annual J.P. Morgan Healthcare ConferenceKala Pharmaceuticals to Present at 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 8 at 3:39 PM
Kala Pharmaceuticals: Rating Buy Ahead Of STRIDE 3 Data This QuarterKala Pharmaceuticals: Rating Buy Ahead Of STRIDE 3 Data This Quarter
seekingalpha.com - January 8 at 7:37 AM
Notable Thursday Option Activity: JPM, XLNX, KALANotable Thursday Option Activity: JPM, XLNX, KALA
www.nasdaq.com - December 26 at 6:24 PM
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - December 19 at 7:41 PM
KALA Kala Pharmaceuticals, Inc. Common StockKALA Kala Pharmaceuticals, Inc. Common Stock
www.nasdaq.com - December 18 at 8:29 AM
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q3 2019 Results - Earnings Call TranscriptKala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 8:37 AM
Kala Pharmaceuticals (KALA) Reports Q3 Loss, Misses Revenue EstimatesKala Pharmaceuticals (KALA) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - November 7 at 2:43 PM
Kala Pharmaceuticals EPS misses by $0.04, misses on revenueKala Pharmaceuticals EPS misses by $0.04, misses on revenue
seekingalpha.com - November 7 at 8:11 AM
Kala Pharmaceuticals Reports Third Quarter 2019 Financial ResultsKala Pharmaceuticals Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 7 at 8:11 AM
Kala Pharmaceuticals to Report Third Quarter 2019 Financial Results and Host Conference CallKala Pharmaceuticals to Report Third Quarter 2019 Financial Results and Host Conference Call
finance.yahoo.com - November 4 at 8:02 PM
This page was last updated on 4/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel